CTRI/2021/08/035830
Not Yet Recruiting
N/A
Evaluation of Sensorineural hearing loss in unilateral mucosal type of Chronic Otitis Media
ok Nayak Hospital new delhi0 sites0 target enrollmentTBD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Health Condition 1: H679- Otitis media in diseases classified elsewhere, unspecified ear
- Sponsor
- ok Nayak Hospital new delhi
- Status
- Not Yet Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Both male and female patients
- •2\. Age\- 5\-50 years
- •3\. History of unilateral ear discharge more than 6 months
Exclusion Criteria
- •1\. Bilateral chronic otitis media
- •2\. History of head injury
- •3\. History of Intracranial/ Extracranial complications
- •4\. History of Previous Tympanomastoid surgery
- •5\. History of use of systemic Ototoxic drugs
- •6\. History of acoustic trauma/ chronic noise exposure
- •7\. History of congenital/ syndromic hearing loss
- •8\. Traumatic perforation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Investigation of hearing loss changes in ULTRAHIGH frequency in patients with chronic renal failureIRCT20201112049369N1Islamic Azad University20
Completed
N/A
ongitudinal evaluation of hearing loss and other hearing complaints in professional musiciansHearing impairmentMusic induced hearing loss10019243NL-OMON48954Klinische en Experimentele Audiologie63
Completed
N/A
The investigation of mobile jammer's effect on hearingHearing loss.Conductive hearing loss,bilateralIRCT2015050922173N1Shiraz University of Medical Sciences70
Not Yet Recruiting
N/A
Effect of unilateral conductive hearing loss and its therapy on neuronal activity of the auditory sys-tem – a PET, MRI/DMI, fNIRS and microphenomenologic studyH90.1Conductive hearing loss, unilateral with unrestricted hearing on the contralateral sideDRKS00033812niklinik Freiburg160
Active, Not Recruiting
N/A
?Idiopathic sudden sensorineural hearing loss treatment by Infliximab injection (TNF-alfa blocker)? - NDEUCTR2007-004074-10-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI